REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/21/2025
Back to search
Official data from USPTO
DRH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/22/2025
Trademark type
Word
Nice classes
1, 5
Filing date
12/17/2019
Registration date
07/21/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2020
Last transaction
07/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
16
Owner location
Ahrensburg, DE
Examiner
KELLEY, EVELYN
Law office
N90
Current location
PETITIONS OFFICE
Holders and representatives
Holders
Abviris Deutschland GmbH
Representatives
Dean W. Amburn Amburn Law PLLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
protein in raw material form for scientific and medical research; proteins for detecting antibodies other than for medical use; diagnostic preparations for scientific or research use; diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use
Class 5
diagnostic agents for medical usetumor markers; diagnostic agentspreparations and substances for medical purposes; antigens for medical purposes; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use; in-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; diagnostic biomarker reagents for medical purposes; protein arrays for diagnosing cancer
Publications
History of USPTO decisions and trademark events.
27 publications found
CORV
REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
01/21/2021
PCGR
PETITION TO DIRECTOR GRANTED
01/16/2021
APET
ASSIGNED TO PETITION STAFF
01/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/17/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/17/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/17/2020
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
08/17/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2020
PUBO
PUBLISHED FOR OPPOSITION
05/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2020
ALIE
ASSIGNED TO LIE
03/26/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/19/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/18/2020
GNSL
LETTER OF SUSPENSION E-MAILED
03/18/2020
CNSL
SUSPENSION LETTER WRITTEN
03/18/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
03/18/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/18/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
03/18/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/18/2020
DOCK
ASSIGNED TO EXAMINER
03/16/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/20/2019
NWAP
NEW APPLICATION ENTERED
12/20/2019
Continuous trademark protection
Get notified about every new filing that threatens DRH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.